20172020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandra Bologna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial

Gennari, A., Foca, F., Zamarchi, R., Rocca, A., Amadori, D., De Censi, A., Bologna, A., Cavanna, L., Gianni, L., Scaltriti, L., Rossi, E., Facchinetti, A., Martini, V., Bruzzi, P. & Nanni, O., Jan 1 2020, (Accepted/In press) In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

  • Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel

    Lorusso, D., Bologna, A., Cecere, S. C., De Matteis, E., Scandurra, G., Zamagni, C., Arcangeli, V., Artioli, F., Bella, M., Blanco, G., Cardalesi, C., Casartelli, C., De Vivo, R., Di Napoli, M., Gisone, E. B., Lauria, R., Lissoni, A. A., Loizzi, V., Maccaroni, E., Mangili, G. & 13 others, Marchetti, C., Martella, F., Naglieri, E., Parolin, V., Ricciardi, G., Ronzino, G., Salutari, V., Scarfone, G., Secondino, S., Spagnoletti, I., Tasca, G., Tognon, G. & Guarneri, V., Jan 1 2020, (Accepted/In press) In : Supportive Care in Cancer.

    Research output: Contribution to journalArticle

  • Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

    Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J. W., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J. Y., Bologna, A., Carrasco-Alfonso, M. J. & 1 others, Harter, P., Nov 1 2019, In : Gynecologic Oncology. 155, 2, p. 186-191 6 p.

    Research output: Contribution to journalArticle

    Open Access
  • Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer: Gynecologic Oncology

    Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J-W., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J-Y., Bologna, A., Carrasco-Alfonso, M. J. & 1 others, Harter, P., 2019, In : Gynecol. Oncol.. 155, 2, p. 186-191 6 p.

    Research output: Contribution to journalArticle

  • Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

    Farolfi, A., Petrone, M., Scarpi, E., Gallà, V., Greco, F., Casanova, C., Longo, L., Cormio, G., Orditura, M., Bologna, A., Zavallone, L., Ventriglia, J., Franzese, E., Loizzi, V., Giardina, D., Pigozzi, E., Cioffi, R., Pignata, S., Giorda, G. & De Giorgi, U., Aug 2018, In : Targeted Oncology. 13, 4, p. 469-479 11 p.

    Research output: Contribution to journalArticle